Gut reactions

By Cristina Luiggi Gut reactions Courtesy of Ivaylo Ivanov, Dan Littman, and Doug Wei The paper H.J. Wu et al., “Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells,” Immunity, 32:815-27, 2010. Free F1000 Evaluation The finding The trillions of microbes that reside in the human gut shape their host’s immune system—for better or for worse. In a mouse model of autoimmune arthritis, Di

By | November 1, 2010

Gut reactions

Courtesy of Ivaylo Ivanov, Dan Littman, and Doug Wei

The paper

H.J. Wu et al., “Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells,” Immunity, 32:815-27, 2010. Free F1000 Evaluation

The finding

The trillions of microbes that reside in the human gut shape their host’s immune system—for better or for worse. In a mouse model of autoimmune arthritis, Diane Mathis from Harvard University and colleagues found that gut bacteria can provoke autoimmune disease in distant parts of the body—the joints.

The surprise

When investigators raised transgenic mice (which develop the disease at 4 weeks of age) in germ-free conditions, the animals developed a milder version of the disease much later. Germ-free mice lack immune cells called T helper 17 cells (Th17), because these cells require the gut bacteria called segmented filamentous bacteria (SFB) to properly develop. When Mathis blocked IL-17—secreted by Th17 cells—in the normally raised mouse model, disease progression was also attenuated.

The link

Mathis and colleagues showed that after SFB induced the accumulation of Th17 cells in the gut, the immune cells traveled to the spleen, where they helped activate antibody-producing B cells. Since the B cells in this mouse model produced self-attacking antibodies that initiated arthritis, the presence of IL-17 acted like a catalyst, quickening the disease. Though more work remains, "it is not hard to imagine the clinical relevance," write Rochelle Marie Hinman and Faculty Member John Cambier.

The future

Mathis and her team are currently investigating how this bacterium drives the development of the Th17 cells.

F1000 evaluators: C. Fagundes and M. Teixeira (Univ Federal de Minas Gerais) • A. Ho and S. Gaffen (Univ Pittsburgh) • E.C. Snow (Univ Kentucky) • R.M. Hinman and J. Cambier (National Jewish Med and Res Ctr)

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies